Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples